Tenax Therapeutics, Inc.
NASDAQ:TENX · NASDAQ Capital Market
+$0.10 today
Vol 2.05M · Avg 0.62M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+113.52%
Period High
$18.27
Period Low
$5.62
Latest
$12.00
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Q32 Bio Inc.
NASDAQ:QTTB
$161.43M
AN2 Therapeutics, Inc.
NASDAQ:ANTX
$134.68M
Verrica Pharmaceuticals Inc.
NASDAQ:VRCA
$62.15M
SAB Biotherapeutics, Inc.
SABS
$37.92M
Boundless Bio, Inc.
BOLD
$31.90M
Minerva Neurosciences, Inc.
NERV
$29.44M
Pluri Inc.
PLUR
$19.78M
Plus Therapeutics, Inc.
PSTV
$10.19M
Jasper Therapeutics, Inc.
JSPR
$7.49M
NextCure, Inc.
NXTC
$5.47M
What is the latest TENX filing?
The latest filing shown is SC 13G/A dated Jun 5, 2026.
How many recent filings does TENX have?
Intrinsic Alpha currently shows 20 recent filings for TENX.
Explore More
Continue the stock analysis
Jump to another research area for this company.